LT3324938T - Vietinio veikimo kompozicijos ir gydymo būdai - Google Patents

Vietinio veikimo kompozicijos ir gydymo būdai

Info

Publication number
LT3324938T
LT3324938T LTEPPCT/US2016/042843T LT16042843T LT3324938T LT 3324938 T LT3324938 T LT 3324938T LT 16042843 T LT16042843 T LT 16042843T LT 3324938 T LT3324938 T LT 3324938T
Authority
LT
Lithuania
Prior art keywords
treatments
compositions
local action
local
action
Prior art date
Application number
LTEPPCT/US2016/042843T
Other languages
English (en)
Inventor
Hemant ALUR
James HARWICK
Original Assignee
Trilogic Pharma Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trilogic Pharma Llc filed Critical Trilogic Pharma Llc
Publication of LT3324938T publication Critical patent/LT3324938T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LTEPPCT/US2016/042843T 2015-07-20 2016-07-18 Vietinio veikimo kompozicijos ir gydymo būdai LT3324938T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562194518P 2015-07-20 2015-07-20
PCT/US2016/042843 WO2017015232A1 (en) 2015-07-20 2016-07-18 Topical formulations and treatments

Publications (1)

Publication Number Publication Date
LT3324938T true LT3324938T (lt) 2021-11-25

Family

ID=57835134

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/US2016/042843T LT3324938T (lt) 2015-07-20 2016-07-18 Vietinio veikimo kompozicijos ir gydymo būdai

Country Status (11)

Country Link
US (3) US11129896B2 (lt)
EP (1) EP3324938B1 (lt)
CA (3) CA2993012C (lt)
DK (1) DK3324938T3 (lt)
ES (1) ES2891754T3 (lt)
HU (1) HUE056401T2 (lt)
LT (1) LT3324938T (lt)
MX (2) MX390004B (lt)
PL (1) PL3324938T3 (lt)
PT (1) PT3324938T (lt)
WO (1) WO2017015232A1 (lt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3324938B1 (en) 2015-07-20 2021-09-01 Trilogic Pharma Llc Topical formulations and treatments
US11370826B2 (en) 2016-02-09 2022-06-28 Bracco Suisse Sa Recombinant chimeric protein for selectins targeting
AU2022318739A1 (en) * 2021-07-26 2024-02-15 Daré Bioscience, Inc. Compositions for use in the treatment of bacterial vaginosis
EP4376890A2 (en) * 2021-07-26 2024-06-05 Daré Bioscience, Inc. Compositions for use in the treatment of dysmenorrhea
US20260232575A1 (en) 2023-01-19 2026-08-13 Daré Bioscience, Inc. Compositions and techniques for treatment of polycystic ovarian syndrome (pcos) and endometriosis
WO2024155775A2 (en) 2023-01-19 2024-07-25 Dare Bioscience, Inc. Compositions and techniques for treatment of polycystic ovarian syndrome (pcos) and endometriosis
WO2024158951A2 (en) * 2023-01-25 2024-08-02 Dare Bioscience, Inc. Compositions and methods for treating dysmenorrhea

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218023B1 (en) 1997-04-21 2001-04-17 Montell North America, Inc. Co-extruded laminate comprising at least one propylene graft copolymer layer
AU1223099A (en) 1997-11-24 1999-06-15 Zhongming Zeng Pharmaceutical formulation for stimulating the growth of gram-positive bacil li and increasing the acidity in vagina and the use thereof
US20040167223A1 (en) 2002-09-03 2004-08-26 Popp Karl F. Topical antibacterial formulations
CN1311873C (zh) 2004-06-30 2007-04-25 上海复康医药科技发展有限公司 一种温度敏感的阴道用原位凝胶制剂
EP2219608B1 (en) * 2007-12-03 2014-03-19 Trilogic Pharma Llc Self solidifying bioerodible barrier implant
AU2009205314A1 (en) * 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US20100105750A1 (en) * 2008-10-23 2010-04-29 Nycomed Us Inc. Stable metronidazole gel formulations
CN102525884A (zh) 2010-12-19 2012-07-04 复旦大学 一种用于阴道给药的温敏原位凝胶制剂
GB2508777B (en) 2011-08-31 2021-06-23 Berry Plastics Corp Polymeric material for an insulated container
JP2015532945A (ja) 2012-10-26 2015-11-16 ベリー プラスチックス コーポレイション 断熱容器用のポリマー材料
EP3324938B1 (en) 2015-07-20 2021-09-01 Trilogic Pharma Llc Topical formulations and treatments

Also Published As

Publication number Publication date
US20250249105A1 (en) 2025-08-07
CA2993012C (en) 2023-10-03
CA3209380C (en) 2026-06-23
CA2993012A1 (en) 2017-01-26
CA3298548A1 (en) 2026-03-02
WO2017015232A1 (en) 2017-01-26
US20220040306A1 (en) 2022-02-10
PL3324938T3 (pl) 2022-01-10
MX390004B (es) 2025-03-04
EP3324938A1 (en) 2018-05-30
ES2891754T3 (es) 2022-01-31
DK3324938T3 (da) 2021-09-27
CA3209380A1 (en) 2017-01-26
EP3324938A4 (en) 2019-03-13
PT3324938T (pt) 2021-09-21
MX2018000800A (es) 2018-08-16
US11129896B2 (en) 2021-09-28
US12303563B2 (en) 2025-05-20
US20180207275A1 (en) 2018-07-26
HUE056401T2 (hu) 2022-02-28
MX2022001736A (es) 2022-03-11
EP3324938B1 (en) 2021-09-01

Similar Documents

Publication Publication Date Title
IL263680A (en) Combination therapies
PL3277270T3 (pl) Kompozycje i sposoby leczenia niedokrwistości
LT3370770T (lt) Anti-cd38 antikūnų poodinės kompozicijos ir jų panaudojimas
PL3189074T3 (pl) Kompozycje oraz sposoby leczenia i zapobiegania zapaleniom
IL249292A0 (en) Methods and devices for treating pulmonary edema
DK3234133T3 (da) Crispr-baserede sammensætninger og fremgangsmåder til anvendelse
LT3317284T (lt) Benzoksazepino oksazolidinono junginiai ir jų naudojimo būdai
KR20180084891A (ko) 구조 조성물 및 방법
LT3518933T (lt) Gimdos fibromų ir endometriozės gydymo būdai
LT3283107T (lt) Kompozicija apimanti ipilimumabo ir nivolumabo kombinaciją
LT3102555T (lt) Junginių kompozicijos ir jų panaudojimas
LT3212189T (lt) Pakeisti chromanai ir naudojimo būdas
LT3258962T (lt) Mišrios alergenų kompozicijos ir jų panaudojimo būdai
IL247292A0 (en) Antireflective coating compositions and processes thereof
PT3142637T (pt) Formulações e métodos de tratamento de queratina
LT3426285T (lt) Pegilintos urikazės kompozicijos ir dozės
DK3557998T3 (da) Sammensætninger, kompositioner og anvendelsesmetoder
PL3394259T3 (pl) Kompozycje i sposoby zmniejszania ekspresji tau
DK3194564T3 (da) Trichodermasammensætninger og anvendelsesfremgangsmåder
LT3204386T (lt) Pakeistieji aminopurino junginiai, jų kompozicijos ir gydymo būdai jais
MA41794A (fr) Agents thérapeutiques modifiés et compositions associées
LT3200815T (lt) Būdai ir kompozicijos, skirti vėžio gydymui
DK3182962T3 (da) Compositions and uses of amidine derivatives
LT3265126T (lt) Tesofensino ir metoprololio derinio kompozicija
PT3261437T (pt) Compostos e composições fungicidas